Determining the Impact of Ocrelizumab on Chronic Active Lesions in Multiple Sclerosis Utilizing Quantitative Susceptibility Mapping (2556)
Year: 2020
Type: article
Source: Neurology
Institutions: Cornell University, Weill Cornell Medicine
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4389450554
